CAPTRUST Financial Advisors’s Alexion Pharmaceuticals ALXN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q3
Sell
-4,025
Closed -$739K 4920
2021
Q2
$739K Sell
4,025
-8,064
-67% -$1.38M 0.01% 839
2021
Q1
$1.85M Sell
12,089
-21,630
-64% -$3.35M 0.02% 490
2020
Q4
$5.27M Buy
33,719
+2,571
+8% +$330K 0.07% 233
2020
Q3
$3.6M Buy
31,148
+4,478
+17% +$483K 0.06% 253
2020
Q2
$3M Buy
26,670
+24,731
+1,275% +$2.63M 0.05% 289
2020
Q1
$174K Sell
1,939
-916
-32% -$89.9K ﹤0.01% 915
2019
Q4
$308K Buy
2,855
+1,970
+223% +$211K ﹤0.01% 834
2019
Q3
$87K Buy
885
+110
+14% +$12.4K ﹤0.01% 823
2019
Q2
$102K Buy
775
+64
+9% +$8.25K ﹤0.01% 759
2019
Q1
$96K Buy
711
+391
+122% +$48.6K ﹤0.01% 715
2018
Q4
$31K Buy
+320
New +$37.8K ﹤0.01% 895
2018
Q2
Sell
-17
Closed -$2K 1645
2018
Q1
$2K Buy
+17
New +$2.03K ﹤0.01% 1260

Other funds holding ALXN